volume has been extremely anemic, worry about supply, where it is and where is it going. A lot of hype in the beginning and interest now waning. I have seen these situations before and some have had an unpleasant ending.
is starting to come into the high cost new meds, could elevate competition and lower margins. Biotech stocks in my opinion are way overpriced somewhat similar to tech stocks in 2000. All I can say is watch out below!